Hearing Australia Implements New NAL-NL3 Fitting Prescription
Developed by the National Acoustic Laboratories, the system builds on NAL-NL2 and is designed for more precise, personalized hearing aid fittings.
Developed by the National Acoustic Laboratories, the system builds on NAL-NL2 and is designed for more precise, personalized hearing aid fittings.
The campaign, themed “From communities to classrooms: hearing care for all children,” highlights the need for early screening and intervention.
The FDA has approved an expanded indication for Med-El cochlear implants for children seven months and older with bilateral sensorineural hearing loss.
A psychologist explores how humor—when used thoughtfully—can help hearing care professionals connect with patients and better meet their needs.
Frank Lin, MD, PhD, discusses the Know Your Hearing Number campaign and why this concept can help break down barriers to hearing care.
NAL-NL3 is a modernized, modular update to the long-standing NAL-NL2 prescription, designed to better support individual hearing needs.
As the fund’s inaugural supporter, Starkey will help UNICEF deliver early screening, assistive technology, and broader disability support to children worldwide.